Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2BZ6

Orally available Factor7a inhibitor

2BZ6 の概要
エントリーDOI10.2210/pdb2bz6/pdb
関連するPDBエントリー1BF9 1CVW 1DAN 1DVA 1F7E 1F7M 1FAK 1FF7 1FFM 1J9C 1JBU 1KLI 1KLJ 1NL8 1O5D 1QFK 1W0Y 1W2K 1W7X 1W8B 1YGC 1Z6J
分子名称BLOOD COAGULATION FACTOR VIIA, (R)-(4-CARBAMIMIDOYL-PHENYLAMINO)-[5-ETHOXY-2-FLUORO-3-[(R)-TETRAHYDRO-FURAN-3-YLOXY]-PHENYL]-ACETIC ACID, SULFATE ION, ... (6 entities in total)
機能のキーワードserine protease, coagulation, enzyme complex, hydrolase
由来する生物種HOMO SAPIENS (HUMAN)
詳細
細胞内の位置Secreted: P08709 P08709
タンパク質・核酸の鎖数2
化学式量合計34401.28
構造登録者
主引用文献Groebke-Zbinden, K.,Banner, D.W.,Hilpert, K.,Himber, J.,Lave, T.,Riederer, M.A.,Stahl, M.,Tschopp, T.B.,Obst-Sander, U.
Dose-Dependant Antithrombotic Activity of an Orally Active Tissue Factor/Factor Viia Inhibitor without Concomitant Enhancement of Bleeding Propensity.
Bioorg.Med.Chem., 14:5357-, 2006
Cited by
PubMed Abstract: The discovery of a highly potent and selective tissue factor/factor VIIa inhibitor is described. Upon oral administration of its double prodrug in the guinea pig, a dose-dependent antithrombotic effect is observed in an established model of arterial thrombosis without prolonging bleeding time. The pharmacodynamic properties of this selective inhibitor are compared to the behaviour of a mixed factor VIIa/factor Xa inhibitor.
PubMed: 16621574
DOI: 10.1016/J.BMC.2006.03.042
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.6 Å)
構造検証レポート
Validation report summary of 2bz6
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon